Skin close-up

Konceptuell förpackningsdesign. Slutlig produkt kan avvika och är ännu inte godkänd för försäljning.

Auxesis Pharmas huvudprodukt

ASA.P® – Topikal (via huden) smärtblockering för hudsmärta

ASA.P® is Auxesis Pharma’s topical medicine for skin pain, developed for fast, local treatment of irritation, inflammation and pain directly in the skin.

Vetenskapsbaserad utveckling
Topikal behandling
Lokal och riktad verkan

Produktplattform

What is ASA.P®?

It is based on the world’s first stable, liquid form of acetylsalicylic acid (ASA) and is designed to treat pain where it occurs — without burdening the rest of the body.

ASA.P® provides effective pain-control effect for insect bites, wasp stings, jellyfish stings and other skin pain.

ASA.P® is an over-the-counter, topical (via the skin) pain-control medicine applied directly to the skin. It is developed to treat both everyday discomfort and sensitive types of skin pain.

Today, there is no other OTC medicine that removes pain and irritation in the skin in a fast and targeted way. Available products often provide a cooling or temporary effect — but the effect wears off quickly and application must be repeated.

Unlike tablets that act via the bloodstream, ASA.P® is applied locally, which means it:

  • penetrates the skin
  • acts directly where the pain occurs
  • reduces swelling and irritation locally
  • provides faster pain-control than oral alternatives
Hud och topikal behandling

Möjliga användningsområden

Common areas of use

Each formula is developed with precision and thoroughly tested. We use ingredients that act quickly and safely.

01

Mosquito bites

Removes itching, irritation and swelling.

02

Wasp stings

Removes pain, stinging and local inflammation.

03

Jellyfish stings

Removes burning sensation and redness.

04

Herpes and eczema

Reduces discomfort during local outbreaks and irritation.

Behandlingsprincip

Why topical pain-control treatment?

Skin pain often starts locally — from bites, burns, irritation or inflammatory reactions. Despite that, symptoms are often treated with systemic medicines even when the issue is in the skin.

Topical treatment makes it possible to treat pain directly in the skin, where it actually is.

The technology enables you to:

  • treat pain where it occurs
  • avoid unnecessary systemic exposure
  • deliver fast and clear effect
  • reduce the need for other pain medicines
Skin image

Så fungerar principen

How ASA.P® works

ASA.P® is built on Auxesis’ unique stabilization of ASA in liquid form. Acetylsalicylic acid blocks COX-2 — an enzyme that drives inflammation and pain.

ASA.P® is developed for both everyday discomfort and sensitive types of skin pain.

Today there is no other OTC medicine that removes pain and irritation in the skin in a fast and targeted way. Available products often provide a cooling or temporary effect — but the effect wears off quickly and application must be repeated.

01

Appliceras lokalt

Formuleringen appliceras direkt på det aktuella hudområdet.

02

Verkar där problemet finns

Behandlingsprincipen är utvecklad för lokal och riktad verkan.

03

Enkel användning

Utvecklas i praktiska format för konsumenter och vårdpersonal.

Säkerhet och utveckling

Safety and research

ASA.P® is developed in Sweden according to established routines for topical medicines. The work includes, among other things:

  • stability testing
  • toxicology assessments
  • skin penetration studies for topical use
ASA.P products

Concept packaging design. Final product may differ and is not yet approved for sale.

Vetenskaplig fördjupning

Läs mer om forskningen bakom ASA.P

Ta del av Auxesis Pharmas vetenskapliga utveckling och arbetet bakom den topikala produktplattformen.

Läs om vårt vetenskapliga genombrott